Pharmaceutical composition for reducing the symptoms and disease of the respiratory infection caused by human metapneumovirus (HMPV), which comprises at least one agent that neutralises the function of the TSLP and/or TSLPR and/or OX40L and/or CD177 molecules, and a pharmaceutically acceptable excipient, and the use thereof (Australia, concesión n° 2016402264)

dc.catalogadorjca
dc.contributor.authorKalergis Parra, Alexis Mikes
dc.contributor.authorBueno Ramírez, Susan Marcela
dc.contributor.authorLay, Margarita K.
dc.date.accessioned2025-05-07T16:47:59Z
dc.date.available2025-05-07T16:47:59Z
dc.date.concesion05-12-2024
dc.date.created15-11-2018
dc.descriptionPatente de invención
dc.estado.patenteCONCEDIDA
dc.fuente.origenPropiedad intelectual
dc.identifier.UAFacultad de Ciencias Biológicas
dc.identifier.concesion2016402264
dc.identifier.govdoc2016402264
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/104069
dc.information.autorucFacultad de Ciencias Biológicas; Kalergis Parra, Alexis Mikes; 0000-0001-7622-5263; 90610
dc.information.autorucFacultad de Ciencias Biológicas; Bueno Ramirez, Susan Marcela; 0000-0002-7551-8088; 113541
dc.information.autorucFacultad de Ciencias Biológicas; Lay, Margarita K.; S/I; 90429
dc.language.isoen
dc.nota.accesosin adjunto
dc.paisAustralia
dc.presentacionExtranjera no prioridad
dc.rightsregistro bibliográfico
dc.solicitantePontificia Universidad Católica de Chile
dc.subjectSalud
dc.subjectTratamientos de enfermedades infecciosas
dc.subject.ddc608
dc.subject.deweyTecnologíaes_ES
dc.territorialidadExtranjera
dc.titlePharmaceutical composition for reducing the symptoms and disease of the respiratory infection caused by human metapneumovirus (HMPV), which comprises at least one agent that neutralises the function of the TSLP and/or TSLPR and/or OX40L and/or CD177 molecules, and a pharmaceutically acceptable excipient, and the use thereof (Australia, concesión n° 2016402264)
dc.typepatente
sipa.codpersvinculados90610
sipa.codpersvinculados113541
sipa.codpersvinculados90429
Files